NO812762L - Fremgangsmaate til fremstilling av nye polyazaheterocykliske forbindelser. - Google Patents

Fremgangsmaate til fremstilling av nye polyazaheterocykliske forbindelser.

Info

Publication number
NO812762L
NO812762L NO812762A NO812762A NO812762L NO 812762 L NO812762 L NO 812762L NO 812762 A NO812762 A NO 812762A NO 812762 A NO812762 A NO 812762A NO 812762 L NO812762 L NO 812762L
Authority
NO
Norway
Prior art keywords
polyazaheterocyclic
compounds
procedure
preparation
new
Prior art date
Application number
NO812762A
Other languages
English (en)
Norwegian (no)
Inventor
Joerg Frei
Ernst Schweizer
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO812762L publication Critical patent/NO812762L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/50Ketonic radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C07D233/08Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms
    • C07D233/12Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D233/16Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO812762A 1980-08-15 1981-08-14 Fremgangsmaate til fremstilling av nye polyazaheterocykliske forbindelser. NO812762L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH619780 1980-08-15

Publications (1)

Publication Number Publication Date
NO812762L true NO812762L (no) 1982-02-16

Family

ID=4305798

Family Applications (1)

Application Number Title Priority Date Filing Date
NO812762A NO812762L (no) 1980-08-15 1981-08-14 Fremgangsmaate til fremstilling av nye polyazaheterocykliske forbindelser.

Country Status (16)

Country Link
EP (1) EP0046446A1 (fr)
JP (1) JPS5754186A (fr)
KR (1) KR830006293A (fr)
AU (1) AU7409281A (fr)
CA (1) CA1173831A (fr)
DD (1) DD201594A5 (fr)
DK (1) DK362381A (fr)
ES (1) ES504736A0 (fr)
FI (1) FI812518L (fr)
GB (1) GB2082577B (fr)
GR (1) GR78233B (fr)
IE (1) IE51498B1 (fr)
IL (1) IL63572A0 (fr)
NO (1) NO812762L (fr)
PT (1) PT73523B (fr)
ZA (1) ZA815621B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60188609A (ja) * 1984-03-07 1985-09-26 株式会社スリ−ボンド セルフロッキングねじ部材の製造方法
JPS61167711A (ja) * 1985-01-17 1986-07-29 株式会社 スリ−ボンド セルフロツキング剤及びセルフロツキングねじ部材
DE3730718A1 (de) * 1987-09-12 1989-03-23 Basf Ag Tetracyclische chinazolinderivate, herstellung und verwendung
US5212310A (en) * 1991-12-19 1993-05-18 Neurogen Corporation Certain aryl fused imidazopyrimidines; a new class of GABA brain receptor ligands

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH422807A (de) * 1963-08-16 1966-10-31 Wander Ag Dr A Verfahren zur Herstellung von Imidazo- und Pyrimidochinazolinen
US3329679A (en) * 1965-12-22 1967-07-04 American Home Prod Fused-ring imidazoquinazolines, pyrimidoquinazolines and related compounds

Also Published As

Publication number Publication date
FI812518L (fi) 1982-02-16
ZA815621B (en) 1982-08-25
DK362381A (da) 1982-02-16
GR78233B (fr) 1984-09-26
DD201594A5 (de) 1983-07-27
KR830006293A (ko) 1983-09-20
GB2082577A (en) 1982-03-10
ES8204992A1 (es) 1982-05-16
IE51498B1 (en) 1987-01-07
CA1173831A (fr) 1984-09-04
IL63572A0 (en) 1981-11-30
ES504736A0 (es) 1982-05-16
EP0046446A1 (fr) 1982-02-24
PT73523A (en) 1981-09-01
JPS5754186A (fr) 1982-03-31
GB2082577B (en) 1984-03-28
IE811860L (en) 1982-02-15
AU7409281A (en) 1982-02-18
PT73523B (en) 1983-08-16

Similar Documents

Publication Publication Date Title
NO822722L (no) Fremgangsmaate til fremstilling av benzazepin-2-oner.
NO156828B (no) Analogifremgangsmaate for fremstilling av antibakterielt virksomme benzoheterocykliske forbindelser.
NO833705L (no) Fremgangsmaate for fremstilling av fenyl-piperidin-propanol-forbindelser.
NO159667C (no) Fremgangsmaate for fremstilling av kikhostetoksid.
NO831792L (no) Fremgangsmaate til fremstilling av nye imidazo-pyrazolopyrimidiner
NO812519L (no) Fremgangsmaate for fremstilling av kolesterase.
NO158743C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive mitosanforbindelser.
NO814047L (no) Fremgangsmaate til fremstilling av 1,2-dikloretan
NO812701L (no) Fremgangsmaate for fremstilling av antibakterielle timetyl-cefalosporiner.
NO145926C (no) Fremgangsmaate til fremstilling av store islegemer
NO813814L (no) Fremgangsmaate for fremstilling av monoalkyletere av hydrokinonforbindelser
NO801142L (no) Fremgangsmaate til fremstilling av klordioksyd.
NO157143C (no) Fremgangsmaate for fremstilling av karbapen-2-em-derivater.
NO811751L (no) Fremgangsmaate for fremstilling av 3-pikolin.
NO810114L (no) Fremgangsmaate for fremstilling av kijanimicin.
NO812762L (no) Fremgangsmaate til fremstilling av nye polyazaheterocykliske forbindelser.
NO158422C (no) Analogifremgangsmaate ved fremstilling av nye oksadiazolopyrimidin-derivater.
NO811038L (no) Fremgangsmaate til fremstilling av insulin.
NO154193C (no) Fremgangsmaate for fremstilling av monohydratisert picotamid
NO800251L (no) Fremgangsmaate til fremstilling av beta-laktamforbindelser
NO822185L (no) Fremgangsmaate for fremstilling av nye derivater av benzoylfenylpiperidin.
NO842385L (no) Fremgangsmaate til fremstilling av nye benzofenoner.
NO159726C (no) Fremgangsmaate til stabilisering av nye halogeneringsforbindelser.
NO853450L (no) Fremgangsmaate til fremstilling av sulfonderivater
NO150513C (no) Fremgangsmaate til fremstilling av 2-halogen-3-sulfonyl-akrylnitriler.